William M. Scalzulli
Directeur/Membre du Conseil chez Dune Medical Devices Ltd.
Profil
William M.
Scalzulli is currently a Director at Dune Medical Devices Ltd.
and Dune Medical Devices, Inc. He previously served as a Director at Acetylon Pharmaceuticals, Inc., Spero Therapeutics, Inc., and C4 Therapeutics, Inc. He holds a graduate degree from Boston University and an undergraduate degree from Northeastern University.
Postes actifs de William M. Scalzulli
| Sociétés | Poste | Début |
|---|---|---|
Dune Medical Devices Ltd.
 Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel. | Directeur/Membre du Conseil | - |
Dune Medical Devices, Inc.
 Dune Medical Devices, Inc. Medical SpecialtiesHealth Technology Dune Medical Devices, Inc. engages in the development, manufacture, and commercialization of medical devices for cancer surgery providing real-time tissue characterization systems. It focuses guiding on surgical and diagnostic decisions. The company was founded by Dan Hashimshony in 2002 and is headquartered in Alpharetta, GA. | Directeur/Membre du Conseil | - |
Anciens postes connus de William M. Scalzulli
| Sociétés | Poste | Fin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/06/2020 |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
| SPERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de William M. Scalzulli
| Northeastern University | Undergraduate Degree |
| Boston University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel. | Health Technology |
Dune Medical Devices, Inc.
Dune Medical Devices, Inc. Medical SpecialtiesHealth Technology Dune Medical Devices, Inc. engages in the development, manufacture, and commercialization of medical devices for cancer surgery providing real-time tissue characterization systems. It focuses guiding on surgical and diagnostic decisions. The company was founded by Dan Hashimshony in 2002 and is headquartered in Alpharetta, GA. | Health Technology |
